Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Levl Joins National Effort to Accelerate Pediatric Medical Device Innovation


News provided by

Levl

Aug 22, 2024, 14:37 ET

Share this article

Share toX

Share this article

Share toX


Levl, an early-stage digital health venture, announced its participation in the Public-Private Partnership for Pediatric Medical Devices (PMD-PPP). This important program is a collaborative effort led by the US National Institutes of Health (NIH) and the Food and Drug Administration (FDA). The partnership includes leading medical device companies such as Johnson & Johnson, Philips, and Medtronic, as well as renowned children's hospitals like Children's National Hospital, Children's Hospital of Orange County (CHOC), and Lurie Children's Hospital of Chicago.

BROOKLYN, N.Y., Aug. 22, 2024 /PRNewswire-PRWeb/ -- Levl, a digital health startup, joins the Public-Private Partnership for Pediatric Medical Devices (PMD-PPP) alongside leaders like Johnson & Johnson, Philips, and top US children's hospitals. Led by the US National Institutes of Health (NIH) and the Food and Drug Administration (FDA), this partnership aims to accelerate pediatric medical device innovation. As the sole startup in this initiative, Levl brings cutting-edge expertise and a startup perspective to support the development of safe, effective, and age-appropriate medical devices for children. This collaboration underscores Levl's commitment to improving pediatric healthcare outcomes through advanced technology and strategic partnerships.

Addressing a Critical Need in Children's Healthcare
Children have unique healthcare needs, but the development of medical devices specifically designed for them lags behind those for adults. This can lead to children being treated with adult devices that are not ideally suited for their smaller bodies or specific medical conditions. The PMD-PPP aims to close this gap by fostering a national network dedicated to pediatric medical device innovation.

"Collaborating with the FDA, NIH, and leading children's hospitals ensures this initiative addresses the real-world challenges innovators face in bringing medical devices to youth who need them." Artin Perse, Co-Founder & CEO of Levl.

Post this

Collaboration with Government, Industry Leaders, and Children's Hospitals
The program brings together a diverse group of experts from government, industry, and clinical care to tackle the complex challenges of pediatric medical device development. By combining the resources and expertise of these key stakeholders, the PMD-PPP aims to accelerate the creation of safe, effective, and age-appropriate devices for children.

Levl's Role and Commitment
As the sole startup in this partnership, Levl brings a fresh and innovative perspective to the PMD-PPP. Levl's expertise in developing digital health technologies will contribute significantly to advancing pediatric medical device R&D and commercialization. "Collaborating with the FDA, NIH, and leading children's hospitals ensures this initiative addresses the real-world challenges innovators face in bringing medical devices to youth who need them." said Artin Perse, Co-Founder & CEO of Levl. "We are honored to collaborate with such esteemed partners and contribute to improving pediatric health outcomes."

Program Goals
From 2023-2025, the PMD-PPP will develop a comprehensive plan to support the pediatric medical device ecosystem. This includes establishing clear pathways for funding, regulatory approval, and commercialization of new devices. The ultimate goal is to ensure that children have access to safe, effective, and age-appropriate medical devices.

Public-Sector Partners

  • U.S. Food and Drug Administration (FDA)
  • U.S. National Institutes of Health (NIH)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • National Institute of Biomedical Imaging and Bioengineering (NIBIB)
  • Biomedical Advanced Research and Development Authority (BARDA)

Private-Sector Partners

- AdvaMed 
- American Academy of Pediatrics 
- Berlin Heart 
- Children's National Hospital 
- Children's Hospital of Orange County (CHOC) 
- CobiCure 
- Charles H. Hood Foundation 
- Johnson & Johnson 
- Lurie Children's Hospital of Chicago 
- MedStar Research Institute 
- OrthoPediatrics 
- Philips 
- Texas A&M 
- Veeva MedTech 
- Levl

About Levl
Levl is an early-stage digital health venture developing a Remote Therapeutic Monitoring (RTM) platform to support clinicians and adolescents in optimizing mental health medication treatments.

For More Information 
For more information about the PMD-PPP and Levl's involvement, please contact:

FNIH Contact:

  • Stacey Adam, Ph.D., Vice President, Science Partnerships, [email protected]
  • Juan Esparza-Trujillo, M.S., GLPCP, GMPCP, Senior Project Manager, Science Partnerships, Translational Science, [email protected]
  • Aimee Ahmed, Director, Strategic Alliances and Advancement, [email protected]

Levl Contact:
Nathan Dubois, Head of Marketing, [email protected], 347-770-2447, findlevl.com

SOURCE Levl

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.